| Dec'19 | Dec'18 | Dec'17 | Dec'16 | |||
|---|---|---|---|---|---|---|
Revenue | ||||||
0 | 0 | 0 | 0 | |||
Operating expenses: | ||||||
Research and development | ||||||
59,208 | 41,340 | 27,899 | 5,782 | |||
General and administrative | ||||||
23,761 | 18,623 | 7,828 | 3,486 | |||
Total operating expenses | ||||||
82,969 | 59,963 | 35,727 | 9,268 | |||
Loss from operations | ||||||
-82,969 | -59,963 | -35,727 | -9,268 | |||
Interest and other income, net | ||||||
6,200 | 2,448 | 236 | 163 | |||
Total other income (expense), net | ||||||
- | - | - | -163 | |||
Net loss | ||||||
-76,769 | -57,515 | -35,491 | -9,431 | |||
Accretion of redeemable convertible preferred stock to redemption value | ||||||
- | 88 | 213 | 107 | |||
Cumulative dividends on redeemable convertible preferred stock | ||||||
- | - | 437 | 197 | |||
Reversal of cumulative dividends on redeemable convertible preferred stock | ||||||
- | - | 634 | - | |||
Net loss attributable to common stockholders | ||||||
-76,769 | -57,603 | -35,507 | -9,735 | |||
Net loss per share, basic and diluted | ||||||
-2.07 | -3.13 | -19.12 | -65.15 | |||
Weighted average common shares outstanding, basic and diluted | ||||||
37,014 | 18,389 | 1,856 | 149 | |||
Comprehensive loss: | ||||||
Net loss | ||||||
-76,769 | -57,515 | -35,491 | -9,431 | |||
Other comprehensive income: | ||||||
Unrealized gains on marketable securities | ||||||
16 | -8 | - | - | |||
Total other comprehensive income | ||||||
16 | -8 | - | - | |||
Total comprehensive loss | ||||||
-76,753 | -57,523 | -35,491 | -9,431 | |||